Ane Uranga

1.6k total citations
44 papers, 520 citations indexed

About

Ane Uranga is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ane Uranga has authored 44 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 14 papers in Infectious Diseases and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ane Uranga's work include Pneumonia and Respiratory Infections (22 papers), Sepsis Diagnosis and Treatment (10 papers) and COVID-19 Clinical Research Studies (9 papers). Ane Uranga is often cited by papers focused on Pneumonia and Respiratory Infections (22 papers), Sepsis Diagnosis and Treatment (10 papers) and COVID-19 Clinical Research Studies (9 papers). Ane Uranga collaborates with scholars based in Spain, United States and Argentina. Ane Uranga's co-authors include Pedro Pablo España, José M. Quintana, Amaia Bilbao, Alberto Capelastegui, Antoní Torres, Jesús Camino, Maider Intxausti, Catia Cillóniz, J.L. Lobo and Rafael Zalacaín and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Ane Uranga

42 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ane Uranga Spain 13 327 102 99 93 78 44 520
Jiun‐Ting Wu Taiwan 10 230 0.7× 66 0.6× 85 0.9× 44 0.5× 61 0.8× 13 409
Emre Alhan Türkiye 13 255 0.8× 61 0.6× 29 0.3× 73 0.8× 39 0.5× 39 516
Laveta Stewart United States 11 206 0.6× 236 2.3× 35 0.4× 31 0.3× 52 0.7× 30 760
Michaëla A. M. Huson Netherlands 12 195 0.6× 46 0.5× 114 1.2× 24 0.3× 56 0.7× 20 392
Benjamin Clouzeau France 11 85 0.3× 94 0.9× 83 0.8× 18 0.2× 42 0.5× 20 412
Rama Thyagarajan United States 9 437 1.3× 62 0.6× 49 0.5× 118 1.3× 39 0.5× 17 742
Nathalie M. Delfos Netherlands 12 410 1.3× 60 0.6× 58 0.6× 35 0.4× 24 0.3× 23 532
Egidio Franco Viganò Italy 6 111 0.3× 47 0.5× 80 0.8× 24 0.3× 19 0.2× 8 352
Emily A. Thorell United States 15 220 0.7× 51 0.5× 19 0.2× 84 0.9× 59 0.8× 33 516
Antonio Macor Italy 8 274 0.8× 92 0.9× 214 2.2× 25 0.3× 23 0.3× 13 489

Countries citing papers authored by Ane Uranga

Since Specialization
Citations

This map shows the geographic impact of Ane Uranga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ane Uranga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ane Uranga more than expected).

Fields of papers citing papers by Ane Uranga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ane Uranga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ane Uranga. The network helps show where Ane Uranga may publish in the future.

Co-authorship network of co-authors of Ane Uranga

This figure shows the co-authorship network connecting the top 25 collaborators of Ane Uranga. A scholar is included among the top collaborators of Ane Uranga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ane Uranga. Ane Uranga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urrechaga, Eloísa, Patricia Aspichueta, César Martı́n, et al.. (2025). Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort. Biomolecules. 15(3). 393–393. 1 indexed citations
2.
España, Pedro Pablo, Ane Uranga, José M. Quintana, et al.. (2024). Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence. Age and Ageing. 53(11).
3.
Fernández, Leyre Serrano, Luis Alberto Ruiz, Sílvia Pérez-Fernández, et al.. (2023). Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing. International Journal of Infectious Diseases. 134. 106–113. 1 indexed citations
4.
Ruiz, Luis Alberto, Leyre Serrano Fernández, Sílvia Pérez-Fernández, et al.. (2023). Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia. Infection. 51(5). 1319–1327. 6 indexed citations
5.
España, Pedro Pablo, et al.. (2023). Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents. Aging Clinical and Experimental Research. 35(8). 1771–1778. 1 indexed citations
6.
Méndez, Raúl, Paula González‐Jiménez, Ana Latorre, et al.. (2023). Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?. Frontiers in Medicine. 10. 1236142–1236142. 2 indexed citations
7.
García-García, Fernando, Dae‐Jin Lee, Isabel Urrutia, et al.. (2023). Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia. The Science of The Total Environment. 894. 164877–164877. 20 indexed citations
8.
Fernández, Leyre Serrano, Luis Alberto Ruiz, Sílvia Pérez-Fernández, et al.. (2022). Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia. Journal of Infection. 85(6). 644–651. 2 indexed citations
9.
Menéndez, Rosario, Raúl Méndez, Paula González‐Jiménez, et al.. (2022). Early Recognition of Low-Risk SARS-CoV-2 Pneumonia. CHEST Journal. 162(4). 768–781. 5 indexed citations
10.
Pascual-Guàrdia, Sergi, Francesco Amati, Judith Marín‐Corral, et al.. (2022). Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Archivos de Bronconeumología. 59(2). 90–100. 8 indexed citations
11.
Tabernero, Eva, Luis Alberto Ruiz, Pedro Pablo España, et al.. (2021). COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences. Infection. 50(1). 179–189. 15 indexed citations
12.
Uranga, Ane, Iratxe Lafuente, Nerea González, et al.. (2021). Factores de riesgo de deterioro clínico en pacientes ingresados por COVID-19: estudio caso-control. Revista Clínica Española. 222(1). 22–30. 2 indexed citations
13.
Uranga, Ane, Amaia Bilbao, José M. Quintana, et al.. (2020). Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia. BMC Pulmonary Medicine. 20(1). 261–261. 4 indexed citations
14.
Aróstegui, Inmaculada, Javier Moraza, Irantzu Barrio, et al.. (2019). <p>COPD classification models and mortality prediction capacity</p>. International Journal of COPD. Volume 14. 605–613. 17 indexed citations
15.
Ruiz, Luis Alberto, Leyre Serrano Fernández, Pedro Pablo España, et al.. (2019). Factors influencing long-term survival after hospitalization with pneumococcal pneumonia. Journal of Infection. 79(6). 542–549. 12 indexed citations
16.
Rosa, David de la, Ane Uranga, Rosário Madero, et al.. (2018). ¿Cómo realizamos el cribado de infección tuberculosa latente en pacientes candidatos a terapias biológicas en España? Una encuesta multidisciplinar. Archivos de Bronconeumología. 54(10). 510–517. 3 indexed citations
17.
Uranga, Ane & Pedro Pablo España. (2018). Long-term Mortality in Community-acquired Pneumonia. Archivos de Bronconeumología. 54(8). 412–413. 8 indexed citations
18.
Esteban, Cristóbal, Inmaculada Aróstegui, Myriam Aburto, et al.. (2016). Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time. PLoS ONE. 11(9). e0161710–e0161710. 14 indexed citations
19.
Uranga, Ane, et al.. (2008). Espectro clínico de tuberculosis cutánea. Anais Brasileiros de Dermatologia. 89(3). 177–187. 3 indexed citations
20.
Uranga, Ane, et al.. (2002). Monitorización por el Servicio de Farmacia de pacientes con potasio sérico alterado, relacionándolo con la función renal y la toma de fármacos que alteran el potasio. Farmacia Hospitalaria. 26(6). 335–339. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiun‐Ting Wu Breakdown of academic impact, for papers by Emre Alhan Breakdown of academic impact, for papers by Laveta Stewart Breakdown of academic impact, for papers by Michaëla A. M. Huson Breakdown of academic impact, for papers by Benjamin Clouzeau Breakdown of academic impact, for papers by Rama Thyagarajan Breakdown of academic impact, for papers by Nathalie M. Delfos Breakdown of academic impact, for papers by Egidio Franco Viganò Breakdown of academic impact, for papers by Emily A. Thorell Breakdown of academic impact, for papers by Antonio Macor
Rankless by CCL
2026